MUDr. Pavel Fabian, Ph.D.
Total number of publications: 136
2022
-
Role of miR-653 and miR-29c in downregulation of CYP1A2 expression in hepatocellular carcinoma
Pharmacological Reports, year: 2022, volume: 74, edition: 1, DOI
2021
-
An Independent Validation Study of Candidate microRNAs as Predictive Biomarkers for Bevacizumab-based Therapy in Patients With Metastatic Colorectal Cancer
In vivo, year: 2021, volume: 35, edition: 5, DOI
-
Neoadjuvant Chemotherapy of Triple-Negative Breast Cancer: Evaluation of Early Clinical Response, Pathological Complete Response Rates, and Addition of Platinum Salts Benefit Based on Real-World Evidence
Cancers, year: 2021, volume: 13, edition: 7, DOI
-
The use of cisplatin in patients after kidney transplantation with chronic renal insufficiency Is the benefit higher than potential risks in therapy of non-seminomatous germ cell tumors?
Medicine, year: 2021, volume: 100, edition: 24, DOI
2020
-
Comprehensive Molecular Profiling for Relapsed/Refractory Pediatric Burkitt Lymphomas-Retrospective Analysis of Three Real-Life Clinical Cases-Addressing Issues on Randomization and Customization at the Bedside
Frontiers in Oncology, year: 2020, volume: 9, edition: FEB 2020, DOI
2019
-
18F-FDG pozitivní kolorektální polyp připomínající metastázu pokročilého melanomu léčeného ipilimumabem.
Nukleární medicína. 2019, roč. 8, č. 2,, year: 2019, volume: 2019, edition: 2
-
GAPPS - syndrom adenokarcinomu žaludku a mnohočetné polypózy žaludku v 8 rodinách testovaných v Masarykově onkologickém ústavu – prevence vč. profylaktické gastrektomie
Klinická onkologie, year: 2019, volume: 32, edition: Supplementum 2, DOI
-
MiR-376b-3p Is Associated With Long-term Response to Sunitinib in Metastatic Renal Cell Carcinoma Patients
CANCER GENOMICS & PROTEOMICS, year: 2019, volume: 16, edition: 5, DOI
-
miR-376b-3p jako biomarker odpovědi na léčbu sunitinibem u pacientů s metastatickým karcinomem ledviny.
Year: 2019, type: Conference abstract
2018
-
Catechol-O-methyltransferase: a dual-role player in different breast cancer subtypes?
Year: 2018, type: Conference abstract